Literature DB >> 30809628

Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers.

Mari Archer1, Olli Kampman2,3, Aini Bloigu4, Risto Bloigu4, Kaisa Luoto2,3, Johanna Kultti5, Mari Hämäläinen6, Eeva Moilanen6, Esa Leinonen1, Onni Niemelä5.   

Abstract

AIMS: Alcohol consumption has been suggested a major role in the pathogenesis and prognosis of depression. However, reliable identification of hazardous drinking continues to be problematic. We compared the accuracy of different biomarkers and self-reports of alcohol consumption in the follow-up study of depression.
METHODS: Data from 202 patients with major depressive disorder were obtained through self-reports, AUDIT and AUDIT-C questionnaires and biomarker analyses. The clinical assessments and measurements of biomarkers (GT, CDT, GT-CDT-combination, MCV, ALT, AST, hs-CRP, IL-6) were performed at baseline and after six months of treatment. Based on self-reported alcohol intake at baseline the patients were classified to three subgroups.
RESULTS: About 27.2% of patients were categorized to high-risk drinkers, 26.3% low-risk drinkers and 46.5% abstainers. High-risk drinkers showed significantly higher mean values of GT, CDT, GT-CDT-combination and IL-6 than abstainers, diagnostic accuracy being highest with the combined marker of GT-CDT. The accuracy of AUDIT and AUDIT-C to detect high-risk drinking was also significant. During follow-up, the differences observed in the biomarkers at baseline disappeared together with recovery from depression.
CONCLUSIONS: Our data suggest the combined use of GT-CDT and AUDIT questionnaires to improve the identification of drinking of patients with depression. This approach could be useful for improving treatment adherence and outcome in depressed patients.
© The Author(s) 2019. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Keywords:  CDT; GT; alcohol; depression; interleukin; liver

Mesh:

Substances:

Year:  2019        PMID: 30809628     DOI: 10.1093/alcalc/agz002

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  3 in total

1.  Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders.

Authors:  Maria Cristina Petralia; Emanuela Mazzon; Katia Mangano; Paolo Fagone; Roberto Di Marco; Luca Falzone; Maria Sofia Basile; Ferdinando Nicoletti; Eugenio Cavalli
Journal:  Exp Ther Med       Date:  2020-01-02       Impact factor: 2.447

2.  The role of alcohol use and adiposity in serum levels of IL-1RA in depressed patients.

Authors:  Mari Archer; Onni Niemelä; Mari Hämäläinen; Eeva Moilanen; Esa Leinonen; Olli Kampman
Journal:  BMC Psychiatry       Date:  2022-03-02       Impact factor: 3.630

3.  Alcohol Consumption and Its Influence on the Clinical Picture of Puumala Hantavirus Infection.

Authors:  Laura Tervo; Tuula K Outinen; Satu Mäkelä; Jenna Mustalahti; Heini Huhtala; Ilkka Pörsti; Jaana Syrjänen; Jukka T Mustonen; Onni Niemelä
Journal:  Viruses       Date:  2022-02-28       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.